Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$49,264,155
-$2,748,499 QoQ
Shares Held
939,797
-0.3% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#46
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $21,591,255,986 across 16 Drug Manufacturers - General names. GSK ranks #12 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,590,218 | $5,505,645,627 | |
| 2 | ABBV |
AbbVie Inc.
|
19,925,232 | $5,013,985,374 | |
| 3 | AZN |
Astrazeneca PLC
|
16,511,727 | $3,130,953,667 | |
| 4 | JNJ |
Johnson & Johnson
|
10,086,602 | $2,561,694,303 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,548,585 | $2,511,993,169 | |
| 6 | NVO |
Novo Nordisk A S
|
13,041,109 | $625,190,761 | |
| 7 | NVS |
Novartis AG
|
3,251,281 | $509,540,755 | |
| 8 | AMGN |
Amgen Inc
|
1,365,550 | $494,492,960 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,264,155 | 939,797 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $52,012,654 | 942,429 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,434,680 | 212,779 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $8,506,359 | 197,089 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,262,449 | 137,043 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $8,130,476 | 209,873 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,358,675 | 158,447 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,621,024 | 235,348 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $8,347,145 | 216,809 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,893,008 | 184,115 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,384,289 | 64,336 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,310,354 | 63,734 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,244,070 | 62,965 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,872,538 | 52,629 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,715,075 | 48,807 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,798,171 | 61,100 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,942,205 | 162,603 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $8,436,164 | 197,459 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,659,130 | 200,196 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,032,080 | 160,957 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,906,871 | 100,034 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,304,465 | 65,833 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,426,090 | 67,217 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $2,529,461 | 68,517 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,401,328 | 60,023 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,423,211 | 38,297 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||